Milan, Italy

Maria Grazia Daidone

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fondazione Irccs “Instituto Nazionale Dei Tumori”. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Grazia Daidone. Retrieved from https://idiyas.com/inventor/maria-grazia-daidone

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Grazia Daidone: Innovator in Cancer Therapeutics

Introduction

Maria Grazia Daidone is a prominent inventor based in Milan, Italy. With a strong commitment to advancing cancer treatment, she has made significant contributions to the field through her innovative research.

Latest Patents

She holds one patent titled "4-oxo-N-(4-hydroxyphenyl)retinamide derivatives as therapeutic agents for the treatment of cancer." This invention relates to a compound having a specific formula and its pharmaceutically acceptable salt, demonstrating its potential use as a therapeutic agent in oncology.

Career Highlights

Maria Grazia Daidone works at the Fondazione IRCCS "Istituto Nazionale dei Tumori," where she focuses on cancer research and treatment development. Her dedication to improving patient outcomes through innovative therapies showcases her vital role in the medical field.

Collaborations

In her work, Maria collaborates with notable colleagues such as Valentina Appierto and Paola Tiberio. Together, they contribute to groundbreaking research aimed at combating cancer, highlighting the importance of teamwork in scientific advancements.

Conclusion

Maria Grazia Daidone's innovative spirit and commitment to cancer treatment exemplify the impact that dedicated inventors can have on healthcare. Her contributions to therapeutic agents represent a promising step forward in the fight against cancer, inspiring future research and innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…